Cargando…

Do Patients with Second Primary Colorectal Cancer Hold the Similar Prognosis and Therapeutic Benefits as Those with Initial Primary Colorectal Cancer?

AIM: The objective is to compare the differences on prognosis and the therapeutic benefits between initial and second primary colorectal cancer (pCRC). METHODS: A dataset containing 377,271 initial pCRC cases and 18,617 second pCRC cases from the National Cancer Institute's Surveillance, Epidem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Quan, Zhao, Shan, Song, Yongxi, Gao, Peng, Sun, Jingxu, Chen, Xiaowan, Sun, Yu, Wang, Zhenning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136497/ https://www.ncbi.nlm.nih.gov/pubmed/30228986 http://dx.doi.org/10.1155/2018/6172670

Ejemplares similares

A nomogram for predicting bowel obstruction in preoperative colorectal cancer patients with clinical characteristics
por: Lv, Xinger, et al.
Publicado: (2019)

Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer
por: Huang, Xuanzhang, et al.
Publicado: (2015)

Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis
por: Huang, Xuanzhang, et al.
Publicado: (2014)

Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis
por: Yang, Yuchong, et al.
Publicado: (2016)

Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials
por: Sun, Jingxu, et al.
Publicado: (2012)

MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer
por: Shi, Jinxin, et al.
Publicado: (2021)

Predicting the effect of 5‐fluorouracil–based adjuvant chemotherapy on colorectal cancer recurrence: A model using gene expression profiles
por: Chen, Quan, et al.
Publicado: (2020)

The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer
por: Fu, Yu, et al.
Publicado: (2021)

Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers
por: Sun, Jingxu, et al.
Publicado: (2014)

Prognostic evaluation of platelet to lymphocyte ratio in patients with colorectal cancer
por: Lu, Chong, et al.
Publicado: (2017)

Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis
por: Sun, Jingxu, et al.
Publicado: (2013)

Prognostic value of gastric cancer‐associated gene signatures: Evidence based on a meta‐analysis using integrated bioinformatics methods
por: Wang, Jun, et al.
Publicado: (2018)

Prognostic value of pretreatment standardized uptake value of F-18-fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysis
por: Wu, Zhonghua, et al.
Publicado: (2017)

Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer
por: Ma, Bin, et al.
Publicado: (2016)

Second primary colorectal cancer after the initial primary colorectal cancer
por: Yang, Lin, et al.
Publicado: (2018)

Quantitative global proteome and lysine succinylome analyses provide insights into metabolic regulation and lymph node metastasis in gastric cancer
por: Song, Yongxi, et al.
Publicado: (2017)

Screening of Potential Biomarkers for Gastric Cancer with Diagnostic Value Using Label-free Global Proteome Analysis
por: Song, Yongxi, et al.
Publicado: (2020)

The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer
por: Song, Yongxi, et al.
Publicado: (2017)

The Efficacy and Toxicity of Paclitaxel Plus S-1 Compared With Paclitaxel Plus 5-Fu for Advanced Gastric Cancer: A PRISMA Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Liu, Huan, et al.
Publicado: (2014)

Second Primary Cancers Following Colorectal Cancer
por: Huh, Jung Wook
Publicado: (2014)

Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis
por: Sun, Jingxu, et al.
Publicado: (2016)

Second primary malignancies in colorectal cancer patients
por: Halamkova, Jana, et al.
Publicado: (2021)

Clinical characteristics of second primary cancer in colorectal cancer patients: the impact of colorectal cancer or other second cancer occurring first
por: Sun, Li-Chu, et al.
Publicado: (2014)

Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis
por: Chen, Xiaowan, et al.
Publicado: (2016)

A panel consisting of three novel circulating lncRNAs, is it a predictive tool for gastric cancer?
por: Liu, Jingjing, et al.
Publicado: (2018)

Excessive risk of second primary cancers in young‐onset colorectal cancer survivors
por: He, Xingkang, et al.
Publicado: (2018)

Second Primary Cancers following Colorectal Cancer in Sicily, Italy
por: Collatuzzo, Giulia, et al.
Publicado: (2022)

The risk of developing second primary malignancies among colorectal cancer patients
por: Du, Songtao, et al.
Publicado: (2022)

Second Primary Malignancies in Patients with Colorectal Cancer: A Population‐Based Analysis
por: Jia, Huixun, et al.
Publicado: (2020)

Long noncoding RNAs in gastric cancer: functions and clinical applications
por: Wang, Jiajun, et al.
Publicado: (2016)

Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients
por: You, Xia-Hong, et al.
Publicado: (2019)

Risk of Second Primary Malignancies Based on the Histological Subtypes of Colorectal Cancer
por: Wu, Meijuan, et al.
Publicado: (2021)

Clinical Characteristics of Colorectal Cancer Patients With a Second Primary Cancer
por: Lee, Jin Woo, et al.
Publicado: (2014)

Machine Learning in Prediction of Second Primary Cancer and Recurrence in Colorectal Cancer
por: Ting, Wen-Chien, et al.
Publicado: (2020)

Prognostic Value of Preoperative Fibrinogen for Predicting Clinical Outcome in Patients with Nonmetastatic Colorectal Cancer
por: Sun, Yu, et al.
Publicado: (2020)

Risk of second primary colorectal cancer among colorectal cancer cases: A population-based analysis
por: Raj, Kavitha P., et al.
Publicado: (2011)

The differences on efficacy of oxaliplatin in locally advanced colon cancer between mucinous and nonmucinous adenocarcinoma
por: Yu, Dehao, et al.
Publicado: (2018)

The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients
por: Halamkova, Jana, et al.
Publicado: (2021)

The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta‐analysis
por: Zhong, Xi, et al.
Publicado: (2018)

Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer
por: Chung, Joo Won, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4rhtdqcl6qfl5rsbvcv5rdhm6a